Showing results (571-580 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|July 15, 2025
Establishment and Verification of Risk Prediction Model for Adverse Outcomes After Hip Arthroplasty in Elderly PatientsJie Ding, Guoli Sun, Yifei Ren, et al.Therapeutics and Clinical Risk Management|July 16, 2025
The Effect of Repairing the Integrity of the Calcaneofibular Ligament During Calcaneal Fracture Surgery on Postoperative Ankle Joint FunctionZhenfeng Huang, Mengni Chen, Zhiwei YeTherapeutics and Clinical Risk Management|July 16, 2025
Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research DirectionsSidao Zheng, Jun Guo, Qi WangTherapeutics and Clinical Risk Management|December 8, 2025
Modified Alberta Stroke Program Early CT Score (ASPECTS) of Contrast Extravasation on Dual-Energy CT Predicts Haemorrhagic Transformation and Poor Outcome After Endovascular ThrombectomyXinyi Chen, Jie Xu, Sheng Zhang, et al.Therapeutics and Clinical Risk Management|January 27, 2025
Improving Patient Outcomes in mTBI: The Role of Integrated Nursing Interventions in the Emergency DepartmentTing Feng, Peng Zhao, Jiao Wang, et al.Therapeutics and Clinical Risk Management|January 30, 2025
Video Laryngoscopy for Endotracheal Intubation: A Consideration for Manual In-Line Stabilization Without Cervical Collar Versus Full ImmobilizationKasamon Aramvanitch, Sittichok Leela-Amornsin, Welawat Tienpratarn, et al.Therapeutics and Clinical Risk Management|February 26, 2025
The Impact of Early Protein Advancement in Critically Ill Patients with COVID-19: A Multicenter Cardinality Matching StudyAbdulrahman Alissa, Ghazwa B Korayem, Ohoud Aljuhani, et al.Therapeutics and Clinical Risk Management|February 24, 2025
Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass GraftingQian Su, Zhipeng Deng, Xiangqing Wei, et al.Therapeutics and Clinical Risk Management|January 16, 2025
The Role of Intravenous Selexipag in Managing PAH and Bridging Gaps in Oral Treatment: A Narrative ReviewSienna Goren, Nermeen Kidwai, Wilbert S Aronow, et al.Therapeutics and Clinical Risk Management|January 13, 2025
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-ChemotherapyWeiguo Gu, Jiaming Tang, Penghui Liu, et al.Pageof 256